GlassScriptPhysician profile
Gabriel J Perry
NPI 1558322255
$3,905.36
in general payments reported to CMS, 2019-2025
23 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $471 · 2021: $675 · 2022: $528 · 2023: $688 · 2024: $368 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,474 · Entertainment: $50.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,473.53 |
| Entertainment | $50.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $753.39 | 2019-2021 | |
| Oyster Point Pharma, INC. | $487.12 | 2022-2024 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $411.22 | 2019-2025 | Xelpros, Cequa, Bromsite |
| Alcon Vision LLC | $378.86 | 2019-2025 | Tryptyr, Wavelight, Rocklatan |
| Johnson & Johnson Surgical Vision, INC. | $274.50 | 2019-2023 | Tecnis Iol, Catalys System |
| Kala Pharmaceuticals, INC. | $268.77 | 2020-2022 | |
| Bausch & Lomb Americas INC. | $260.74 | 2022-2025 | Miebo, Vyzulta, Scoutpro Osmolarity System |
| Allergan, INC. | $212.61 | 2019-2022 | |
| Carl Zeiss Meditec USA, INC. | $153.19 | 2023 | |
| Eyevance Pharmaceuticals LLC | $151.41 | 2019-2022 | |
| Rxsight INC | $96.96 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Dompe US, INC. | $69.96 | 2024-2025 | Oxervate |
| Abbvie INC. | $53.81 | 2023-2025 | |
| Optos, INC. | $50.42 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Tarsus Pharmaceuticals, INC. | $49.82 | 2024-2025 | Xdemvy |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $42.55 | 2025 | Iyuzeh |
| Ocular Therapeutix, INC. | $38.18 | 2023 | Dextenza |
| Novartis Pharmaceuticals Corporation | $37.20 | 2019-2022 | |
| Harrow Eye, LLC | $28.03 | 2025 | Vevye |
| Aerie Pharmaceuticals, INC. | $23.59 | 2021 | |
| Sight Sciences, INC. | $22.14 | 2021 | |
| Biotissue Holdings INC. | $21.57 | 2023 | |
| Rayner Intraocular Lenses Limited | $19.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.